GlassScriptPhysician profile
Fatema Billah
NPI 1710538731
$1,241.77
in general payments reported to CMS, 2019-2025
18 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $192 · 2023: $154 · 2024: $462 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $933.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $310.12 | 2022-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $142.16 | 2021-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Sanofi Pasteur INC. | $125.12 | 2023-2025 | |
| Corium, LLC | $109.30 | 2021-2022 | |
| Cranial Technologies, INC | $97.38 | 2023-2025 | Doc Band |
| Glaxosmithkline, LLC. | $80.08 | 2024 | Bexsero, Rotarix, Pediarix |
| Pfizer INC. | $60.45 | 2024-2025 | |
| Biomarin Pharmaceutical INC. | $58.93 | 2025 | Voxzogo 1.2mg |
| Seqirus USA INC | $54.33 | 2024-2025 | Flucelvax |
| Abbvie INC. | $39.04 | 2022-2023 | |
| Organon LLC | $28.50 | 2025 | |
| Biogen, INC. | $26.88 | 2025 | Spinraza |
| Sanofi-Aventis U.S. LLC | $22.12 | 2025 | |
| Sobi, INC | $22.08 | 2021 | |
| Azurity Pharmaceuticals, INC. | $21.98 | 2025 | Alvesco |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15.90 | 2024 | Id Now Instrument |
| Tolmar Pharmaceuticals, INC. | $13.77 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $13.63 | 2025 | Kristalose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fatema Billah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.